Evidence map›Paper›PMID 42332631›Full record

Trial reportBMC complementary medicine and therapies2026

Effect of Citrus aurantium capsules on peripartum anxiety and postpartum blues: a randomized triple -blind clinical trial.

Fatemeh Ahmadinia, Farangis Sharifi, Hourivash Ghaderi, Fatemeh Deris, Sheida Shabanian

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fatemeh AhmadiniaDepartment of medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Farangis SharifiDepartment of Midwifery, Faculty of Nursing and Midwifery, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Hourivash GhaderiDepartment of Psychiatry, School of Medicine, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Fatemeh DerisDepartment of Epidemiology and Biostatistics, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Sheida ShabanianDepartment of Gynecology and Obstetrics, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran. sheidashabanian@yahoo.com.ORCID http://orcid.org/0000-0002-2785-8723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimMaternal anxiety and blue during pregnancy and postpartum can have significant negative effects on mother, child and family. In recent years, the people of Iran, like other countries in the world have paid special attention to the use of medicinal plants due to the side effects of chemical drugs, one of the medicinal plants with sedative and anti-anxiety effects is Citrus aurantium. The aim of this study was to investigate the effect of Citrus aurantium capsules on peripartum anxiety and postpartum blues.

methodsIn the present clinical trial, 100 pregnant women with anxiety diagnosis were included in the study and randomly divided into control and case groups. The intervention group received 500 mg of Citrus aurantium capsule twice daily and the control group received placebo for 6 weeks (two weeks after delivery). Beck Anxiety Questionnaire was completed before the intervention, immediately after delivery and 2 weeks after delivery, and the postpartum blues checklist was completed immediately after delivery and 2 weeks after delivery. Data were analyzed by SPSS software.

resultsThe mean anxiety score of the control group at two weeks postpartum was significantly lower than before the intervention (P < 0.05) but at the time of delivery was not significantly different from before the intervention. The mean score of anxiety in the intervention group during delivery and two weeks after delivery was significantly lower than before the intervention (P < 0.05). The mean score of anxiety in the intervention group during the study period was significantly lower than the control group (P < 0.05). The frequency of labor grief during labor in the control and intervention groups did not show a significant difference (P > 0.05), but two weeks after delivery the frequency of labor grief in the intervention group with 28% was significantly lower than the control group with It was 54% (P < 0.05).

conclusionCitrus aurantium capsule reduces anxiety during and after childbirth and is recommended for use in anxious patients. TRIAL NUMBER: IRCT20210926052594N1 Registration date: 2021-10-09.

Indexed as

Anti-Anxiety AgentsAnxietyCitrusPregnancy ComplicationsAdultCapsulesFemaleHumansIranPeripartum PeriodPostpartum PeriodPregnancyAnti-Anxiety AgentsCapsulesAnxietyBlueCitrus aurantiumPeripartumPostpartum

Identifiers

PMID42332631
PMCPMC13536629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.